Log in
Enquire now
Revolo Biotherapeutics

Revolo Biotherapeutics

Therapies designed to achieve long-term disease remission with less frequent doses.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Also Known As
Immune Regulation
Legal Name
Immune Regulation Limited
Company Operating Status
Active
Country
United Kingdom
United Kingdom
Crunchbase URL
crunchbase.com/organiz...gulation
Facebook URL
@revolobio
Founded Date
2011
Full Address
900 Camp St, New Orleans, Louisiana 70130, US
Headquarters
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
Industry
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Immunotherapy
Immunotherapy
Technology
Technology
Health technology
Health technology
‌
Deep Tech
Autoimmune disease
Autoimmune disease
Diagnosis
Diagnosis
Biomedical engineering
Biomedical engineering
Engineering
Engineering
•••
Instagram URL
instagram.com/revolobio/
Investors
‌
Morningside Technology Ventures
24Haymarket
24Haymarket
Latest Funding Round Date
2020
Latest Funding Round Amount (USD)
40,600,000
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/revolobiotherapeutics
Location
United Kingdom
United Kingdom
New Orleans
New Orleans
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...125506-45
Total Funding Amount (USD)
40,600,000
Twitter URL
@revolobio
Official Website
immuneregulation.com
revolobio.com

Find more companies like Revolo Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.